West Family Investments Inc. Purchases Shares of 7,690 The Cooper Companies, Inc. $COO

West Family Investments Inc. acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 7,690 shares of the medical device company’s stock, valued at approximately $551,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in COO. Heartland Advisors Inc. acquired a new position in Cooper Companies during the fourth quarter worth approximately $15,348,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in Cooper Companies by 6.0% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 421,948 shares of the medical device company’s stock worth $34,224,000 after buying an additional 23,896 shares during the last quarter. Swedbank AB lifted its position in Cooper Companies by 18.8% in the fourth quarter. Swedbank AB now owns 1,074,029 shares of the medical device company’s stock valued at $88,027,000 after purchasing an additional 170,000 shares during the period. Capital International Inc. CA lifted its holdings in shares of Cooper Companies by 22.9% in the 4th quarter. Capital International Inc. CA now owns 118,210 shares of the medical device company’s stock valued at $9,688,000 after buying an additional 22,054 shares during the period. Finally, SEB Asset Management AB acquired a new stake in Cooper Companies in the first quarter valued at $22,823,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

COO has been the subject of a number of research reports. Needham & Company LLC reduced their price target on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Robert W. Baird decreased their price target on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a research note on Friday, June 5th. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research note on Friday, June 5th. Piper Sandler set a $86.00 target price on shares of Cooper Companies and gave the company an “overweight” rating in a report on Monday, June 1st. Finally, UBS Group initiated coverage on Cooper Companies in a research note on Tuesday, July 28th. They set a “neutral” rating and a $75.00 price target for the company. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $81.64.

Cooper Companies Price Performance

COO opened at $76.73 on Thursday. The company has a fifty day simple moving average of $71.59 and a 200 day simple moving average of $71.16. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The firm has a market cap of $14.96 billion, a price-to-earnings ratio of 65.03, a PEG ratio of 1.98 and a beta of 0.83. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter in the previous year, the firm posted $0.96 earnings per share. The company’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.